Literature DB >> 21311929

Assessment of pure single nerve root resection in the treatment of spinal schwannoma: focus on solitary spinal schwannomas located below the thoracolumbar junction.

Nobuhisa Satoh1, Yurito Ueda, Munehisa Koizumi, Toshichika Takeshima, Jin Iida, Koji Shigematsu, Hideki Shigematsu, Hiroaki Matsumori, Yasuhito Tanaka.   

Abstract

BACKGROUND: The incidence of neurological deficits is reportedly low after sacrificing the affected nerve root during spinal schwannoma treatment. Although the incidence has been widely reported, the operative method for nerve root resection has been not clarified. To evaluate the safety of pure nerve root resection, we focused on solitary spinal schwannomas below the thoracolumbar level and investigated the effect of affected nerve resection.
METHODS: Twenty-three spinal schwannoma patients were retrospectively examined. The mean age at surgery was 53 years. We investigated preoperative symptoms, duration of the disorder, postoperative neurological deficits, and clinical outcomes. In addition, we measured tumor size on computed tomography after myelography or on magnetic resonance images using image-analysis software. We retrospectively assessed correlations among duration of symptoms, tumor size, and postoperative neurological deficits.
RESULTS: The tumors comprised 19 intradural schwannomas and 4 dumbbell-shaped schwannomas. No postoperative neurological deficits were observed in the intradural schwannoma patients. In contrast, three of the four dumbbell-shaped schwannoma patients experienced postoperative neurological deficits. Among these three patients, two recovered quickly whereas one never recovered. The mean duration of the disorder was 29 months. The postoperative modified JOA score (13.0) was significantly improved compared with the preoperative score (8.9). The mean maximum tumor sizes were 97.2 mm(2) for the intradural schwannomas and 884.0 mm(2) for the dumbbell-shaped schwannomas. There were no correlations among tumor size, duration of the disorder, and postoperative neurological deficits.
CONCLUSIONS: On the basis of this study, we recommend pure single nerve resection for treatment of intradural spinal schwannomas before such tumors progress and involve other normal roots, because postoperative neurological deficits did not occur in our intradural schwannoma patients, irrespective of tumor size, when this procedure was used. However, dumbbell-shaped schwannoma patients should be carefully treated operatively, because high incidence of postoperative neurological deficits can be expected.

Entities:  

Mesh:

Year:  2011        PMID: 21311929     DOI: 10.1007/s00776-011-0032-8

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  5 in total

1.  Granular cell tumors of the spinal canal: intramedullary case report and a review of the literature.

Authors:  Kilian G M Brown; Prashanth J Rao; Than-Htike Oo; Adam Fowler
Journal:  J Spine Surg       Date:  2015-12

2.  Three-dimensional conformal fractionated radiotherapy for spinal schwannoma with a paravertebral or an intraosseous component.

Authors:  Rikiya Onimaru; Kazutoshi Hida; Naoki Takeda; Shunsuke Onodera; Yukiko Nishikawa; Takashi Mori; Hiroki Shirato
Journal:  Jpn J Radiol       Date:  2015-10-27       Impact factor: 2.374

3.  An extremely giant lumbar schwannoma: new classification (kotil) and mini-open microsurgical resection.

Authors:  Kadir Kotil
Journal:  Asian Spine J       Date:  2014-08-19

4.  Clinical Characteristics and Treatment Strategy of Retroperitoneal Schwannoma Adjacent to Important Abdominal Vessels: Three Case Reports and Literature Review.

Authors:  Qi Wu; Bingqiang Liu; Jun Lu; Hong Chang
Journal:  Front Surg       Date:  2021-01-14

5.  Single root multiple spinal schwannomas: Case report, treatment strategy and review of literature.

Authors:  Augustinas Fedaravičius; Avner Michaeli; Victor Diomin; Tehila Kaisman Elbaz; Arimantas Tamašauskas; Israel Melamed
Journal:  Int J Surg Case Rep       Date:  2020-08-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.